Literature DB >> 32193741

Gut and Metabolic Hormones Changes After Endoscopic Sleeve Gastroplasty (ESG) Vs. Laparoscopic Sleeve Gastrectomy (LSG).

Gontrand Lopez-Nava1, Anuradha Negi1, Inmaculada Bautista-Castaño1, Miguel Angel Rubio2, Ravishankar Asokkumar3,4.   

Abstract

INTRODUCTION: ESG reduces gastric lumen similar to LSG and induces significant weight loss. However, the metabolic and physiological alteration after ESG is not fully understood. We aim to study the gastrointestinal hormone changes after ESG and compared it with LSG.
METHODS: We conducted a prospective pilot study comparing ESG and LSG at two centers in Spain. We administered a standard test meal after an overnight fast, and collected blood samples before and after meal. We measured the levels of ghrelin, GLP-1, peptide-YY, insulin, leptin, and adiponectin. We evaluated the hormone profile and weight changes (%TBWL) at baseline and at 6 months after the procedure.
RESULTS: Twenty-four patients were recruited (ESG-12, LSG-12). The baseline age, sex, BMI, and fasting hormone levels were similar between the groups. At 6-month post-ESG, there was a significant decline in the leptin levels. We found a trend towards a decrease in insulin levels and improvement in insulin secretory pattern. We did not observe any change in fasting ghrelin levels, GLP-1, and PYY. At 6 months, LSG induced a significant reduction in the ghrelin, and leptin levels, and increase in peptide-YY, and adiponectin levels, respectively. A trend towards an increase in GLP-1 level was noted. However, no change in insulin was observed. LSG achieved greater %TBWL (24.4 vs. 13.3, p < 0.001) and significantly change in ghrelin, PYY, and adiponectin levels at 6 months compared to ESG.
CONCLUSION: ESG induced gut hormone changes differently as compared to LSG. ESG prevented a compensatory rise in ghrelin and promoted beneficial changes in the insulin secretory pattern with weight loss.

Entities:  

Keywords:  ESG; Hormone changes; LSG; Weight loss

Mesh:

Substances:

Year:  2020        PMID: 32193741     DOI: 10.1007/s11695-020-04541-0

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  7 in total

1.  Short-term changes and correlations of plasma spexin, kisspeptin, and galanin levels after laparoscopic sleeve gastrectomy.

Authors:  Mustafa Atabey; Muhammed Raşid Aykota; Mehmet İlker Özel; Gökhan Arslan
Journal:  Surg Today       Date:  2021-02-08       Impact factor: 2.549

2.  Systematic Review of Innovation Reporting in Endoscopic Sleeve Gastroplasty.

Authors:  Andrew C Currie; Michael A Glaysher; Natalie S Blencowe; Jamie Kelly
Journal:  Obes Surg       Date:  2021-03-27       Impact factor: 4.129

Review 3.  Endoscopic therapy of weight regain after bariatric surgery.

Authors:  Milutin Bulajic; Salvatore Francesco Vadalà di Prampero; Ivo Boškoski; Guido Costamagna
Journal:  World J Gastrointest Surg       Date:  2021-12-27

Review 4.  Nutritional Management and Role of Multidisciplinary Follow-Up after Endoscopic Bariatric Treatment for Obesity.

Authors:  Anuradha Negi; Ravishankar Asokkumar; Rajesh Ravi; Gontrand Lopez-Nava; Inmaculada Bautista-Castaño
Journal:  Nutrients       Date:  2022-08-22       Impact factor: 6.706

5.  What predicts the unsuccess of bariatric surgery? An observational retrospective study.

Authors:  C D'Eusebio; S Boschetti; F Rahimi; G Fanni; A De Francesco; M Toppino; M Morino; E Ghigo; S Bo
Journal:  J Endocrinol Invest       Date:  2020-08-25       Impact factor: 4.256

Review 6.  Bariatric and metabolic endoscopy: impact on obesity and related comorbidities.

Authors:  Amit Mehta; Reem Z Sharaiha
Journal:  Ther Adv Gastrointest Endosc       Date:  2021-06-09

7.  Safety and early efficacy of endoscopic sleeve gastroplasty (ESG) for obesity in a multi-ethnic Asian population in Singapore.

Authors:  Ravishankar Asokkumar; Chin Hong Lim; Ai Shan Tan; Phong Ching Lee; Alvin Eng; Jeremy Tan; Gontrand Lopez-Nava; Sonali Ganguly; Jason Chang; Christopher Khor
Journal:  JGH Open       Date:  2021-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.